MaaT013
- Generic Name
- MaaT013
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Background
MaaT013 is an allogeneic fecal microbiota therapy. It is being investigated for the treatment of Graft-Versus-Host Disease.
- Associated Conditions
- -
- Associated Therapies
- -
Assessing the Tolerance and Clinical Benefit of feCAl tranSplantation in patientS With melanOma
Phase 2
Recruiting
- Conditions
- Melanoma
- Interventions
- First Posted Date
- 2021-08-04
- Last Posted Date
- 2023-09-26
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 60
- Registration Number
- NCT04988841
- Locations
- 🇫🇷
Hôpital Nantes Hôtel Dieu, Nantes, France
🇫🇷Hôpital Saint Louis, Paris, France
🇫🇷Hôpital Gustave Roussy, Villejuif, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath